Spots Global Cancer Trial Database for stage ii nasopharyngeal cancer
Every month we try and update this database with for stage ii nasopharyngeal cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
T-Lymphocytes in Treating Patients With Epstein-Barr Virus-Positive Nasopharyngeal Cancer, NPC | NCT00609219 | Head and Neck C... | autologous EBV ... | - | Baylor College of Medicine | |
Chemotherapy Plus Radiation Therapy in Treating Patients With Head and Neck Cancer | NCT00002951 | Esophageal Canc... Head and Neck C... | fluorouracil hydroxyurea surgical proced... radiation thera... | - | University of Chicago | |
Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer | NCT00019201 | Head and Neck C... Lung Cancer | cytology specim... immunohistochem... sputum cytology bronchoscopic a... bronchoscopy comparison of s... endoscopic biop... | 18 Years - | National Cancer Institute (NCI) | |
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | NCT00004261 | Breast Cancer Cervical Cancer Head and Neck C... Prostate Cancer Sarcoma | EF5 flow cytometry fluorescent ant... immunohistochem... biopsy | 18 Years - 120 Years | University Health Network, Toronto | |
Sargramostim in Decreasing Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer | NCT00008398 | Head and Neck C... Oral Complicati... Radiation Toxic... | sargramostim quality-of-life... radiation thera... | - | Radiation Therapy Oncology Group | |
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | NCT00004261 | Breast Cancer Cervical Cancer Head and Neck C... Prostate Cancer Sarcoma | EF5 flow cytometry fluorescent ant... immunohistochem... biopsy | 18 Years - 120 Years | University Health Network, Toronto | |
Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer | NCT01254591 | Breast Cancer Colorectal Canc... Esophageal Canc... Head and Neck C... Lung Cancer | 18F-fluoromison... fluorescence an... laboratory biom... infrared thermo... magnetic resona... therapeutic con... [18F]-ML-10 fludeoxyglucose... rubidium Rb-82 | - | National Cancer Institute (NCI) | |
Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer | NCT00019201 | Head and Neck C... Lung Cancer | cytology specim... immunohistochem... sputum cytology bronchoscopic a... bronchoscopy comparison of s... endoscopic biop... | 18 Years - | National Cancer Institute (NCI) | |
Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer | NCT00019201 | Head and Neck C... Lung Cancer | cytology specim... immunohistochem... sputum cytology bronchoscopic a... bronchoscopy comparison of s... endoscopic biop... | 18 Years - | National Cancer Institute (NCI) | |
Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the Nasopharynx | NCT00025298 | Drug/Agent Toxi... Head and Neck C... Oral Complicati... Radiation Toxic... | amifostine trih... carboplatin cisplatin paclitaxel radiation thera... | 15 Years - 70 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
Iseganan Hydrochloride in Preventing Oral Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer | NCT00022373 | Head and Neck C... Oral Complicati... Radiation Toxic... | iseganan HCl or... management of t... | 18 Years - | National Cancer Institute (NCI) |